期刊文献+

血清癌抗原125对卵巢恶性肿瘤诊断及监测复发的价值 被引量:1

Diagnostic and recurrence value of serum CA125 on malignant ovarian tumor
下载PDF
导出
摘要 目的 :探讨癌抗原 12 5 (CA12 5 )对卵巢恶性肿瘤诊断及复发的价值。方法 :应用化学发光法测定了 6 7例卵巢恶性肿瘤、6 2例卵巢良性肿瘤、2 0例子宫内膜异位症及 18例盆腔炎性包块患者血清 CA12 5值。结果 :卵巢恶性肿瘤的血清 CA12 5值及阳性率明显高于其他 3组患者 ,差异有显著性 ;血清 CA12 5值 >2 0 0 u/ m l,诊断卵巢癌的特异性达 10 0 % ,敏感性 4 9.2 5 % ;6 7例中 12例复发患者 CA12 5平均值为 2 0 3.86 u/ ml,8例血清 CA12 5阳性 (6 6 .6 6 % )。结论 :监测血清 CA12 5对卵巢癌的诊断有重要意义 ,对卵巢癌复发的监测亦有一定的价值 ,但不能作为惟一的监测手段。 Objective: To study diagnostic and recur value of serum CA125 on malignant ovarian tumor. Methods By using radiochemistry, CA125 concentration in serum was measured in 67 patients with malignant ovarian tumor, 62 patients with benign ovarian tumor,20 patients with endometriosis and 18 patients with pelvic inflammation. Results the serum CA125 concentration in malignant ovarian tumor was higher than that in other three groups; The peculiar rate (100%) and sensitive rate (49.25%) of ovarian cancer using serum CA125>200u/ml;the serum average CA125 in 12 cases of recurrent ovarian cancer was 203.86u/ml,8 of 12 cases have abnormal CA125(66.66%). Conclusion:It is important to measure serum CA125 for diagnosis of ovarian cancer,and there are some values for recurrent ovarian cancer. But it is not the only measuring method.
作者 姚春凤
出处 《江苏预防医学》 CAS 2004年第2期9-10,14,共3页 Jiangsu Journal of Preventive Medicine
关键词 癌抗原125 卵巢肿瘤 诊断 预测复发 CA125 Ovarian tumor Diagnosis Value
  • 相关文献

参考文献7

  • 1陈勇霞,赵蓉.卵巢肿瘤患者血清CA125,CA199及CEA含量的检测及其意义[J].广东医学,2001,22(1):28-30. 被引量:24
  • 2Bilgin T, Karabay A, Dolar E, et al. Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA125 mimicking advanced ovarian carcinoma: a series of 10 case. Int [J]J Gynecol Cancer, 2001,11 (4): 290-294.
  • 3Chen JT, Yu Kc, Chang M, et al. Use of PAPNET testing to relatuate preceeding negative cervical smears of women with high grade squamous intraepithelial lesion and carcinoma[J].Acta Cytol,1998,42(snapplz) :466.
  • 4Tamakoshi K, Kikkawa F, Shibata K, et al. Clinical value of CA125, CA199,CEA,CA72-4,and TPA in borderline ovarian tumor[J]. Gynecol Oncol, 1996,62 (1) : 67-72.
  • 5Crombach G, Zippel HH, Wurz H. Clinical significance of cancer antigen 125(CA125)in ovarian cancer[J]. Acta Obstet Gynecol Scand, 1998,67 (1): 53-58.
  • 6Negele F, Petru E,Medl M,et al. Preoperative CA125:an independent prognostic factor in patients with stage I epithelial ovarian cancer[J]. Obstet Gynecol, 1995,86(2) :259-264.
  • 7周家德,沙玉成,刘功传.血清CA_(125)在卵巢上皮性癌诊断和预后中的价值[J].中国肿瘤临床与康复,2002,9(3):33-34. 被引量:6

二级参考文献7

共引文献27

同被引文献16

  • 1Moss EL,Hollingworth J,Reynolds TM.The role of CA125 in clinical practice.J Clin Patho1,2005,58(3):308-312.
  • 2Barbieri RL,Niloff JM,Jr Bast R,et al.Elevated serum concentrations of CA-125 in patients with advanced endometriosis.Fertil Steril,1986,45(5):630-634.
  • 3Muyldermans M,Cornillie FJ,Koninckx PR.CA125 and endometriosis.Hum Reprod Update,1995,1(2):173-187.
  • 4Vlahos NF,Kalampokas T,Fotiou S.Endometriosis and ovarian cancer:a review.Gynecol Endocrinol,2010,26(3):213-219.
  • 5Aris a.Endometriosis-associated ovarian cancer:A ten-year cohort study of women living in the estrie region of quebec,Canada.J Ovarian Res,2010:2.
  • 6Gupta D,Lis CG.Role of CA125 in predicting ovarian cancer survival-a review of the epidemiological literature.J Ovarian Res,2009,2(1):13.
  • 7Somigliana E,Vigano P,Tirelli AS,et al.Use of the concomitant serum dosage of CA 125,CA 19-9 and interleukin-6 to detect the presence of endometriosis.Hum Reprod,2004,19(8):1871-1876.
  • 8沈芳华,刘惜时,郭孙伟.子宫内膜异位症复发机制及相关因素的研究进展[J].国外医学(妇产科学分册),2007,34(5):354-358. 被引量:8
  • 9刘爱民.血清CA125和CA19-9水平对子宫内膜异位症诊断价值的探讨[J].放射免疫学杂志,2008,21(1):11-13. 被引量:21
  • 10董艳,周东霞.子宫内膜异位症患者治疗前后血清CA125、VEGF检测的临床意义[J].放射免疫学杂志,2008,21(2):127-129. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部